Optimizing Allelopathy Screening Bioassays by Using Nano Silver.

Plamen Marinov-Serafimov, Irena Golubinova, Nadezhda Zapryanova, Ekaterina Valcheva, Bogdan Nikolov, Slaveya Petrova

Abstract read

In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Plamen Marinov-SerafimovAgricultural Academy, Institute of Decorative and Medicinal Plants, Negovan, 1222 Sofia, Bulgaria.

Irena GolubinovaAgricultural Academy, Institute of Decorative and Medicinal Plants, Negovan, 1222 Sofia, Bulgaria.

Nadezhda ZapryanovaAgricultural Academy, Institute of Decorative and Medicinal Plants, Negovan, 1222 Sofia, Bulgaria.

Ekaterina ValchevaAgricultural University, 12 Mendeleev Blvd., 4000 Plovdiv, Bulgaria.

Bogdan NikolovUniversity of Plovdiv Paisii Hilendarski, 24 Tsar Asen Str., 4000 Plovdiv, Bulgaria.

Slaveya PetrovaAgricultural University, 12 Mendeleev Blvd., 4000 Plovdiv, Bulgaria.ORCID 0000-0001-9868-070X

Funding

European Union-NextGenerationEU BG-RRP-2.004-0001-C01

6 · The paper itself

Abstract

Nano solutions are widely used in medicine and also have the potential to be used when performing allelopathy screening studies. The present experiment aimed to test the effectiveness of colloidal nano silver Silver-Amber© with nanoparticles of 20 nm (>20 mg/L at a purity level of 99.99%) as a carrier of allelochemicals in laboratory conditions. The influence of eleven concentrations of Silver-Amber© (0.10, 0.20, 0.39, 0.78, 1.56, 3.13, 6.25, 12.5, 25.0, 50.0 and 100.0%

Indexed as

allelopathybiotestinhibitionnanoparticlesnano solutions

Identifiers

PMID38929669

DOI10.3390/life14060687

PMCPMC11204856

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.